Across TCGA pan-cancer cohorts, PCDHB11 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PCDHB11 data layer compared with 22 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher PCDHB11 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated PCDHB11 expression acts as an unfavorable survival marker.

LSCC and UCEC are the cancer types where PCDHB11 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Tertile	II,III,IV	0.250	1.000	.002	26	view →
UCEC	DFS	Median	II,III,IV	0.386	1.000	.014	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: PCDHB11 tumor-vs-normal RNA expression · all PCDHB11 data types